Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DYRK1A | Q13627 | 12/20 | 0.51 |
| ▸ | WNT1 | P04628 | 9/20 | 0.47 |
| ▸ | PIK3C3 | Q8NEB9 | 2/20 | 0.47 |
| ▸ | GSK3B | P49841 | 1/20 | 0.47 |
| ▸ | WNT3A | P56704 | 2/20 | 0.46 |
| ▸ | JAK2 | O60674 | 1/20 | 0.46 |
| ▸ | CLK2 | P49760 | 3/20 | 0.45 |
| ▸ | CLK3 | P49761 | 3/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31240493 | 0.90 | WNT3A (0.57) | DYRK1AWNT1GSK3BWNT3AJAK2 | |
| SCHEMBL31240509 | 0.88 | JAK2 (0.56) | DYRK1AWNT1GSK3BWNT3AJAK2 | |
| SCHEMBL31240445 | 0.87 | WNT3A (0.47) | DYRK1AWNT1WNT3AJAK2 | |
| SCHEMBL26685765 | 0.87 | MAPK1 (0.54) | DYRK1APIK3C3 | |
| SCHEMBL30633343 | 0.87 | MAPK1 (0.54) | DYRK1APIK3C3 | |
| SCHEMBL31240675 | 0.86 | WNT3A (0.52) | WNT3AJAK2 | |
| SCHEMBL31240382 | 0.85 | MAPK1 (0.52) | DYRK1AGSK3BWNT3ACLK2CLK3 | |
| SCHEMBL31240463 | 0.85 | PSEN1 (0.54) | WNT3AJAK2 | |
| SCHEMBL31240399 | 0.85 | JAK2 (0.54) | WNT3AJAK2CLK2 | |
| SCHEMBL31240240 | 0.84 | MAPK14 (0.55) | GSK3BWNT3AJAK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4705291-A1 | IKK-ALPHA INHIBITORS | Cancer Research Technology Limited (GB) | 2026-03-11 | — | — | EP | claimed |
| WO-2024228035-A1 | IKK-ALPHA INHIBITORS | CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 2024-11-07 | — | — | WO | claimed |
| EP-4705291-A1 | IKK-ALPHA INHIBITORS | Cancer Research Technology Limited (GB) | 2026-03-11 | — | — | EP | disclosed |
| WO-2024228035-A1 | IKK-ALPHA INHIBITORS | CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 2024-11-07 | — | — | WO | disclosed |